Mario Huyghe
Mario Huyghe is the CEO of OnComfort, a leading company in the use of VR and digital technologies in Healthcare.
Mario Huyghe is CEO of Oncomfort, leading Belgian innovative company using virtual reality (VR) in combination with proven clinical techniques to deliver digital sedation in healthcare.
Oncomfort's digital therapy reduces patient's anxiety and pain in an easy and efficient, non-pharmacological way.
Using Oncomfort's medical approved Sedakit(TM), care professionals experience seamless therapy or intervention with significantly better outcome in patient comfort and satisfaction.
Mario built over 25 year experience in healthcare medical systems business. He deployed his career in different regional and global leadership positions in General Electric Healthcare, growing medical devices and information systems business for acute care in hospitals. In 2009, he started his own consulting company and became CEO of the Arseus medical and dental group in Europe, focusing on
first-line care and chronic care.
In 2014, he moved his scope into digital health innovation working with incubators in mobile health and e-health.
In 2016, he became CEO of Philips in Belux to transform the healthcare activity into the digital health solutions for hospital and chronic care support.
In September 2018, he decided to take the step to full digital therapeutics with Oncomfort.
Mario holds an engineering degree and is an MBA alumnus of the Belgian Vlerick Business School.
Oncomfort's solution for digital sedation reduces patient's anxiety and pain in a non-pharmacological way. Care professionals experience an easier and uninterrupted workflow during therapy or intervention with significantly better outcome in patient comfort and satisfaction. Oncomfort offers non-pharmacological digital sedation by combining evidence-based clinical hypnosis and other psychological techniques with virtual reality in its Sedakit(TM) CE-approved medical device. This innovation brings digital sedation into standardized practice, using the Oncomfort Sedakit(TM) which is easy to use by care professionals in pediatric and adult patients. Patients consistently confirm that Oncomfort's digital sedation practically eliminates their traumatic experience around medical interventions. Doctors and nurses experience enormous simplification of patient preparation and handling before, during and after these interventions. This leads to significant gain of time, an earlier discharge and, most importantly, a positive patient and caregivers' experience. Therapeutic indications for using Oncomfort Sedakit(TM) include a wide range of clinical cases where managing pain and anxiety is critical or where patient should be sedated. Sedakit(TM) can be used before, during or after diagnostic or therapeutic interventions. The different Oncomfort digital sedation modules are optimized for specific therapeutic impact, from distraction to full immersion, adapted to caregivers' therapeutic plan, case duration, patient's age and native language. Oncomfort offers formal clinical guidance for use in different indications. With focus on patient's comfort and medical team's seamless experience, Oncomfort's Sedakit(TM) can be put into practice by any trained care professional in a large range of clinical settings and indications. Oncomfort's evidence-based design brings digital sedation immediately into the category of true digital therapeutics. For the first time, sedation and clinical hypnosis are available in standard practice thanks to Oncomfort's Sedakit(TM). Oncomfort Sedakit(TM) for digital sedation Patient experience with Oncomfort
Oncomfort's solution for digital sedation reduces patient's anxiety and pain in a non-pharmacological way. Care professionals experience an easier and uninterrupted workflow during therapy or intervention with significantly better outcome in patient comfort and satisfaction. Oncomfort offers non-pharmacological digital sedation by combining evidence-based clinical hypnosis and other psychological techniques with virtual reality in its Sedakit(TM) CE-approved medical device. This innovation brings digital sedation into standardized practice, using the Oncomfort Sedakit(TM) which is easy to use by care professionals in pediatric and adult patients. Patients consistently confirm that Oncomfort's digital sedation practically eliminates their traumatic experience around medical interventions. Doctors and nurses experience enormous simplification of patient preparation and handling before, during and after these interventions. This leads to significant gain of time, an earlier discharge and, most importantly, a positive patient and caregivers' experience. Therapeutic indications for using Oncomfort Sedakit(TM) include a wide range of clinical cases where managing pain and anxiety is critical or where patient should be sedated. Sedakit(TM) can be used before, during or after diagnostic or therapeutic interventions. The different Oncomfort digital sedation modules are optimized for specific therapeutic impact, from distraction to full immersion, adapted to caregivers' therapeutic plan, case duration, patient's age and native language. Oncomfort offers formal clinical guidance for use in different indications. With focus on patient's comfort and medical team's seamless experience, Oncomfort's Sedakit(TM) can be put into practice by any trained care professional in a large range of clinical settings and indications. Oncomfort's evidence-based design brings digital sedation immediately into the category of true digital therapeutics. For the first time, sedation and clinical hypnosis are available in standard practice thanks to Oncomfort's Sedakit(TM). Oncomfort Sedakit(TM) for digital sedation Patient experience with Oncomfort